研究文章
麻醉的效果4%与2%利多卡因相比Articaine Intraligamentary注射后无效的下牙槽神经阻滞与不可逆转的下颌磨牙牙髓炎:一个前瞻性随机Triple-Blind临床试验
表2
总结下牙槽神经阻滞的平均疼痛评分和articaine intraligamentary注射利多卡因在不同时间(平均±SE =标准错误)。
|
| 疼痛组 |
齿数 |
最初的疼痛 |
在块注射疼痛 |
块注射后疼痛 |
在补充注射疼痛 |
补充注射后疼痛 |
疼痛在访问腔制备过程 |
疼痛主要文件 |
|
| Articaine(均值±SE) 95%可信区间 |
6 |
92.81±4.882.57-103.05 |
19.69±4.69.86-29.51 |
47.81±7.531.81-63.82 |
0.0±0.0 na |
22.94±5.311.60-34.27 |
40.62±7.125.46-55.79 |
26.75±6.013.82-39.68 |
|
7 |
97.0±3.589.42-104.58 |
12.13±3.64.41-19.84 |
41.06±6.826.53-55.60 |
2.0±1.41.01-5.01 |
9.13±2.92.76-15.49 |
18.63±4.010.09-27.16 |
15.13±3.18.42-21.83 |
|
总 |
94.91±2.988.86-100.95 |
15.91±2.99.87-21.95 |
44.4±5.0234.19-54.96 |
1.0±0.70.47-2.47 |
16.03±3.29.41-22.65 |
29.63±4.420.50-38.75 |
20.94±3.513.76-28.12 |
|
| 利多卡因(平均±SE) |
6 |
101±4.990.41-111.71 |
14.63±3.37.55-21.70 |
49.81±7.633.56-66.06 |
0.63±0.40.29-1.54 |
26.81±5.115.93-37.69 |
45.06±5.732.83-57.30 |
28.75±5.317.42-40.08 |
|
7 |
88.63±4.179.79-97.46 |
13.69±3.95.31-22.07 |
35.63±6.222.37-48.88 |
2.81±1.40.26-5.88 |
13.44±3.75.43-21.44 |
25.81±5.613.70-37.93 |
22.75±5.111.78-33.72 |
|
总 |
94.84±3.387.95-101.74 |
14.16±2.58.99-19.32 |
42.72±5.032.51-52.92 |
1.72±0.70.16-3.28 |
20.12±3.313.31-26.94 |
35.44±4.326.60-44.27 |
25.75±3.618.25-33.25 |
|
| 总(平均±SE) |
6 |
96.94±3.489.82-104.05 |
17.16±2.811.38-22.93 |
48.81±5.238.07-59.55 |
0.31±0.20.13-0.76 |
24.88±3.617.45-32.30 |
42.84±4.533.64-52.05 |
27.75±3.919.65-35.85 |
|
7 |
92.81±2.787.12-98.5 |
12.91±2.67.54-18.28 |
38.34±4.529.03-47.65 |
2.41±0.90.38-4.44 |
11.28±2.36.40-16.16 |
22.22±3.415.12-29.32 |
18.94±3.012.73-25.15 |
|
总 |
94.88±2.290.42-99.33 |
15.03±0.911.16-18.9 |
43.58±3.536.55-50.61 |
1.36±0.50.32-2.40 |
18.08±2.313.43-22.72 |
32.53±3.126.31-38.75 |
23.34±2.518.26-28.43 |
|
|
|
|
